Skip to main content
Have a personal or library account? Click to login
Effects of Withania Somnifera (Ashwagandha) Supplementation on Oxidative Stress Response: A Systematic Review of Human and Animal Studies in Various Exercise and Non-Exercise Models Cover

Effects of Withania Somnifera (Ashwagandha) Supplementation on Oxidative Stress Response: A Systematic Review of Human and Animal Studies in Various Exercise and Non-Exercise Models

Open Access
|Jun 2026

Figures & Tables

Table 1

Inclusion criteria.

WEB SEARCH ENGINESPUBMED, SCIENCE DIRECT, SCOPUS, AND WEB OF SCIENCE
Publishing period2011–2025
KeywordPhysical exercise, ashwagandha, and oxidative stress
Language
Type of article
English
Original research article
Full TextArticles matched the purpose and/or topic of the research.
Figure 1

PRISMA flowchart of the article selection process.

Table 2

Summary of the design and intervention of the studies.

AUTHORDESIGNPARTICIPANTSINTERVENTIONOUTCOME
(Babu et al., 2025)Experimental24 rats
  1. Group I: As the negative control, normal rats were fed water (2 ml/kg bw) orally for three weeks.

  2. Group II: As the positive control, rats received an oral gavage of ashwagandha (60 mg/kg bw diluted in distilled water) for three weeks.

  3. Group III: For three weeks, rats were given an oral gavage of aluminum (100 mg/kg bw dissolved in distilled water).

  4. Group IV: Rats given oral gavages of aluminum (100 mg/kg bw) and ashwagandha (60 mg/kg bw) for three weeks.

MDA levels significantly decreased p < 0.05.
(Kuchewar et al., 2014)Experimental30 healthy volunteers
  1. They were divided into three groups at random.

  2. For six months, each group received three differently colored capsules containing 500 mg of ashwagandha, guduchi, and a placebo. Each capsule was given twice a day.

Higher SOD levels and lower MDA levels.
(Priyanka et al., 2020)Experimental24 healthy horses
  1. Four groups of six horses each were created from the horses.

  2. In addition to a regular diet, treatment groups 2, 3, and 4 received ashwagandha root extract combined with brown sugar at different doses for 21 days.

  3. A physical stress intervention was also administered to the horses.

SOD levels increased and cortisol levels decreased following ashwagandha administration.
(Sajid et al., 2025)Experimental14 miceFrom the day of the nerve lesion until the study’s conclusion, mice in the treatment group received an oral dose of ashwagandha at a rate of 25 mg/kg body weight.Total antioxidant status significantly increased and total oxidant status significantly decreased.
(Wankhede et al., 2015)Experimentalparticipants
  1. While the control group took a starch placebo, the subjects in the treatment group took 300 mg of ashwagandha root extract twice a day.

  2. Following baseline measurements, both groups trained with weights for eight weeks. At the conclusion of the eighth week, measurements were taken again.

As evidenced by the stabilization of blood creatine kinase, ashwagandha also significantly decreased exercise-induced muscle damage.
(Hashem et al., 2023)ExperimentalThirty-six mature male Wistar albino rats in good healthMultiple dosages of supplementation were administered to the male Wistar albino rats, including 100 mg/kg body weight, 150 mg/kg body weight, and 200 mg/kg body weight.All dosages of ashwagandha administration raised SOD and total antioxidant levels while lowering MDA levels.
(Tuzcuet al., 2024)ExperimentalTwenty-eight rats were divided into four groups
  1. Sedentary control group: Rats were given physiological saline orally and did not exercise during the trial.

  2. Exercise group: Rats were given physiological saline orally and worked out on a rodent treadmill.

  3. E + JHF 100 group: Rats were given JHF 100 mg/kg (BDMC-enriched curcumin + Ashwagandha + BSE) orally while exercising on a rodent treadmill.

  4. E + JHF 200 group: Rats were given JHF 200 mg/kg (BDMC-enriched curcumin + Ashwagandha + BSE) orally while exercising on a rodent treadmill.

The combined formulation containing curcumin, ashwagandha, and BSE increased antioxidant enzyme activity.
(Bharani et al., 2024)ExperimentalTwenty apparently healthy dogs
  1. Starch that was identical to the research product in terms of appearance, color, odor, and taste was given to the placebo group.

  2. The chosen dogs were given 15 mg/kg body weight of ashwagandha powder or a placebo orally once a day, mixed into their meal.

  3. Owners of dogs were advised to mix the powder evenly into their usual diet based on the animal’s body weight.

MDA levels significantly decreased following ashwagandha administration. In addition, antioxidant markers such as SOD and glutathione increased markedly, accompanied by a significant reduction in serum cortisol levels.
(Bhargavan et al., 2015)ExperimentalAdult male Wistar
  1. Group A: The control was distilled water.

  2. Group B: Ashwagandha 200 mg/kg.

  3. Group C: 4 g/kg of alcohol.

  4. Group D: 4 g/kg of alcohol and 200 mg/kg of ashwagandha after four hours.

  5. For 28 days, which is the amount of time needed for mice to complete the spermatogenesis cycle, all animals in the group were given alcohol and ashwagandha orally.

MDA levels significantly decreased following the administration of ashwagandha supplements.
(Anwer et al., 2012)ExperimentalWistar albino rat
  1. Group I: Citrate control, given a pH 4.5 citrate buffer solution

  2. Group II: Controlling type 2 diabetes with a single intraperitoneal dosage of STZ (100 mg/kg)

  3. Group III: Ashwagandha (200 mg/kg, p.o.) was used to treat type 2 diabetes.

  4. Group IV: Ashwagandha (400 mg/kg, p.o.) was used to treat type 2 diabetes.

Ashwagandha administration significantly increased antioxidant enzyme activities (GPx, GR, GST, SOD, and CAT) compared with type 2 diabetic control mice.
Figure 2

Physical Exercise Increases ROS and Triggers Oxidative Stress (Wibawa et al., 2025).

Figure 3

Various phytochemicals present in Withania somnifera (Garkal et al., 2025).

Figure 4

Pharmacological effects of ashwagandha (Garkal et al., 2025).

DOI: https://doi.org/10.5334/paah.564 | Journal eISSN: 2515-2270
Language: English
Page range: 79 - 95
Submitted on: Mar 25, 2026
Accepted on: Jun 8, 2026
Published on: Jun 23, 2026
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services

© 2026 Novadri Ayubi, Andi Tajrin, Nila Kusuma, Junian Cahyanto Wibawa, Mert Kurnaz, Oce Wiriawan, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.